MetLife Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,194
| Closed | -$636K | – | 2971 |
|
|
2024
Q1 | $636K | Hold |
18,194
| – | – | ﹤0.01% | 1549 |
|
|
2023
Q4 | $691K | Hold |
18,194
| – | – | 0.01% | 1508 |
|
|
2023
Q3 | $334K | Hold |
18,194
| – | – | ﹤0.01% | 1877 |
|
|
2023
Q2 | $472K | Buy |
18,194
+448
| +3% | +$11.6K | ﹤0.01% | 1728 |
|
|
2023
Q1 | $335K | Hold |
17,746
| – | – | ﹤0.01% | 1895 |
|
|
2022
Q4 | $437K | Buy |
17,746
+519
| +3% | +$12.8K | ﹤0.01% | 1727 |
|
|
2022
Q3 | $309K | Hold |
17,227
| – | – | ﹤0.01% | 1997 |
|
|
2022
Q2 | $196K | Hold |
17,227
| – | – | ﹤0.01% | 2335 |
|
|
2022
Q1 | $384K | Buy |
17,227
+5,704
| +50% | +$127K | ﹤0.01% | 1945 |
|
|
2021
Q4 | $503K | Hold |
11,523
| – | – | ﹤0.01% | 1503 |
|
|
2021
Q3 | $384K | Hold |
11,523
| – | – | ﹤0.01% | 1680 |
|
|
2021
Q2 | $317K | Buy |
+11,523
| New | +$317K | ﹤0.01% | 1850 |
|
|
2021
Q1 | – | Sell |
-3,963
| Closed | -$131K | – | 2366 |
|
|
2020
Q4 | $131K | Buy |
+3,963
| New | +$131K | ﹤0.01% | 2181 |
|